Eye cancer is a rare disease, meaning treatment efforts across the world vary and that access to care is not always readily available. The Eye Cancer Foundation supports research efforts that will advance treatment methods and overall the rate at which eyes and lives are saved. With research, eye cancer can be treated.
- Bioinformatic Grid (BIG): The mission of the eye cancer bioinformatics grid is to provide an infrastructure for sharing data, results and research. Dr. Finger says, “There is power in numbers!” Learn more here >
- Working Days: The Working Day unites specialists around the globe to develop multicenter, international collaboration in ocular oncology. The second Eye Cancer Working Day took place March, 24, 2017 in Sydney, Australia. The first Eye Cancer Working Day was held at the Curie Institute in Paris, France on June 15, 2015. Learn more here >
- Doctor reported outcomes: Real-world data from a tertiary eye cancer center Abhilasha Maheshwari, Paul T Finger, Abhishek Malpani, Puneet Jain , Ankit Singh Tomar, Gaurav Garg
- Doppelgänger dilemma: Leiomyoma versus uveal melanoma Ankit Singh Tomar, Anthony Fam, Paul T. Finger, and Codrin E. Iacob
- Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma Amin S, AlJboor M, Toro MD, Rejdak R, Nowomiejska K, Nazzal R, Mohammad M, Al-Hussaini M, Khzouz J, Banat S, AlJabari R, Jaradat I, Mehyar M, Sultan I, AlNawaiseh I, Yousef YA
- Patients presenting with metastases: stage IV uveal melanoma, an international study Gaurav Garg, Paul T Finger, Tero T Kivelä, E Rand Simpson, Brenda L Gallie, Svetlana Saakyan, Anush G Amiryan, Vladimir Valskiy, Kimberly J Chin, Ekaterina Semenova, Stefan Seregard, Maria Filì, Matthew Wilson, Barrett Haik, Josep Maria Caminal, Jaume Catala-Mora, Cristina Gutiérrez, David E Pelayes, Anibal Martin Folgar, Martine Johanna Jager, Mehmet Doğrusöz, Gregorius P M Luyten, Arun D Singh, Shigenobu Suzuki